Metabolic dysfunction-associated steatotic liver disease (SLD) and alcohol-associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10-year follow-up period.

Kazuma MoriMarenao TanakaTatsuya SatoYukinori AkiyamaKeisuke EndoToshifumi OgawaToru SuzukiHiroki AidaWataru KawaharataKei NakataItaru HosakaAraya UmetsuNagisa HanawaMasato Furuhashi

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)

MASLD and ALD, but not SLD-MD[-], are independently associated with the development of CKD.

Keyphrases

chronic kidney disease
end stage renal disease
oxidative stress
alcohol consumption